World-class Friedrich Miescher Institute for Biomedical Research (FMI), based in Basel – Switzerland, has decided to implement Qmarkets’ idea management platform to streamline and enhance internal work processes.
Basel, July 13th, 2018 – As the result of an internal survey where an ideation platform was requested, FMI chose to implement Qmarkets’ Idea Management platform for implementation to their staff of over 350 people, which includes a high number of PhD students and postdoctoral researchers from around the world. The decision was made due to the flexibility of the Qmarkets platform, and its experience with similar life-science companies, specifically in Switzerland.
FMI – which is affiliated with both the Novartis Institutes for Biomedical Research (NIBR), and the University of Basel – conducts a broad array of research projects to better understand the molecular mechanisms of health and disease. In addition to serving as a training institute for students and scientists, FMI is comprised of senior academics, HR personnel, patents and licensing staff, communication executives, and other professionals.
“Idea generation and problem solving methodologies have always played pivotal roles in our ongoing research activities.” said Thibaut Siegmann, Head Knowledge Management at FMI. “The Qmarkets platform has made it easy for us to organize and optimize our innovation workflows on a single, user-friendly platform. In addition to helping us develop strategies that bring together the scientific, technical, and administrative sides of our mission, it’s ideal for helping us discover ways to optimize day-to-day working processes across departments.”
As this is the first time the FMI has experimented with an idea and innovation management platform, they are utilizing Qmarkets’ best-practice features and recommended workflow structure, sending selected ideas to an internal review committee for evaluation.
“We’re extremely proud to see a pioneering biomedical institute like FMI make use of our product for their campaigns” said Qmarkets’ Co-founder, Michael Stilger. “While discussing applications of the platform with the FMI team, we were thrilled by the passion the organization has for innovation.”
About the Friedrich Miescher Institute for Biomedical Research (FMI)
The Friedrich Miescher Institute for Biomedical Research (FMI), based in Basel, Switzerland, is a world-class center for basic research in life sciences. It was founded in 1970 as a joint effort of two Basel-based pharmaceutical companies. It is affiliated with the Novartis Institutes for Biomedical Research (NIBR), and the University of Basel.
The FMI is devoted to the pursuit of fundamental biomedical research. Areas of expertise are neurobiology, quantitative biology, and epigenetics. The institute counts 350 collaborators. The FMI also offers training in biomedical research to PhD students and postdoctoral fellows from around the world. Prof. Susan Gasser has been the Director of the FMI since 2004.
As an established leader on the idea and innovation management landscape, Qmarkets has developed a reputation over the last 10 years for delivering the most comprehensive crowdsourcing software solutions in the world. Recognized by leading analysts such as Gartner, Forrester, and Info-tech, Qmarkets offers unmatched technical and design flexibility to their extensive list of leading global clients; including Nestle, Ford, Lufthansa, Ab InBev, Phillip Morris International, UniCredit, and many more.
Qmarkets’ software offering extends beyond innovation management to include products focusing on process improvement, continuous improvement and operational excellence; open innovation with customers and business partners; technology scouting for enterprise M&A opportunities; and digital employee engagement.
For press inquiries please contact:
Mr. Elliott Wilkins
Marketing Manager, Qmarkets